Sonnet BioTherapeutics Appoints Stephen J. McAndrew, Ph.D., as Chief Business Officer
Position
Chief Business Officer
Company
Sonnet BioTherapeutics Holdings
PrincetonBiotechnologyHealthcareDescription
Sonnet BioTherapeutics Holdings, Inc has announced the appointment of Stephen J McAndrew, PhD, as its Chief Business Officer. Dr McAndrew, with over three decades of experience in the biopharmaceutical industry, will continue to build on his previous roles within the company to further its business development and licensing strategies.
Who to call at Sonnet BioTherapeutics Holdings, and when
A new leader at Sonnet BioTherapeutics Holdings brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Sonnet BioTherapeutics Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sonnet BioTherapeutics Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sonnet BioTherapeutics Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sonnet BioTherapeutics Holdings changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sonnet BioTherapeutics Holdings changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.